Arvinas to Present at Jefferies Global Healthcare Conference

Rhea-AI Summary

Arvinas (NASDAQ: ARVN), a clinical-stage biotech company focused on targeted protein degradation drug development, announced its upcoming participation in the Jefferies Global Healthcare Conference. The company's management will engage in a fireside chat on June 5, 2025, at 2:35 p.m. ET in New York City. Investors and interested parties can access a live audio webcast of the presentation through the company's website under the "Events and Presentations" section of the Investors and Media page.

NEW HAVEN, Conn., May 30, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company working to develop a new class of drugs based on targeted protein degradation, today announced that management will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 5 at 2:35 p.m. ET in New York City.

A live audio webcast of the presentation will be available here and under “Events and Presentations” on the Investors and Media section of the Company’s website.

About Arvinas
Arvinas (Nasdaq: ARVN) is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases. Through its PROTAC (PROteolysis Targeting Chimera) protein degrader platform, Arvinas is pioneering the development of protein degradation therapies designed to harness the body’s natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Arvinas is currently progressing multiple investigational drugs through clinical development programs, including vepdegestrant, targeting the estrogen receptor for patients with locally advanced or metastatic ER+/HER2- breast cancer; ARV-393, targeting BCL6 for relapsed/refractory non-Hodgkin Lymphoma; and ARV-102, targeting LRRK2 for neurodegenerative disorders. Arvinas is headquartered in New Haven, Connecticut. For more information about Arvinas, visit www.arvinas.com and connect on LinkedIn and X. 

Contacts

Investors:
Jeff Boyle
+1 (347) 247-5089
Jeff.Boyle@arvinas.com

Media:
Kirsten Owens
+1 (203) 584-0307
Kirsten.Owens@arvinas.com

FAQ

When is Arvinas (ARVN) presenting at the Jefferies Global Healthcare Conference 2025?

Arvinas will present at the Jefferies Global Healthcare Conference on Thursday, June 5, 2025, at 2:35 p.m. ET in New York City.

How can I watch Arvinas (ARVN) presentation at the Jefferies Healthcare Conference?

The presentation can be accessed via live audio webcast through Arvinas' website under the 'Events and Presentations' section of the Investors and Media page.

What type of company is Arvinas (ARVN)?

Arvinas is a clinical-stage biotechnology company that develops drugs based on targeted protein degradation.

What is the format of Arvinas' (ARVN) presentation at the Jefferies conference?

Arvinas management will participate in a fireside chat format presentation at the conference.